#ppp disease treatment

[sunil-digital]

Health Care System In India

Improving India's healthcare system requires a comprehensive approach that addresses various challenges across accessibility, affordability, quality of care, infrastructure, and healthcare workforce. Here are some key strategies that could help improve the healthcare system in India:

Increase Healthcare Spending: India's healthcare spending as a percentage of GDP is relatively low compared to other countries. Increasing public expenditure on healthcare can help improve infrastructure, expand services, and subsidize healthcare costs for the vulnerable population.

Enhance Infrastructure: Investing in healthcare infrastructure, especially in rural and underserved areas, is crucial. This includes building and upgrading hospitals, clinics, and primary health centers, as well as ensuring availability of essential medical equipment and medicines.

Strengthen Primary Healthcare: Focus on strengthening the primary healthcare system to provide comprehensive and preventive care at the grassroots level. This includes increasing the number of trained healthcare workers, improving diagnostic capabilities, and promoting health education and awareness.

Regulate and Standardize Healthcare Services: Implement and enforce regulations to ensure quality standards in healthcare facilities across the board, both public and private. This includes accreditation processes, regular inspections, and adherence to clinical protocols.

Promote Health Insurance Coverage: Expand health insurance coverage to more citizens, particularly those from low-income groups, to reduce out-of-pocket expenses and ensure financial protection during medical emergencies.

Address Healthcare Workforce Shortages: Address the shortage of healthcare professionals by increasing medical and nursing school capacity, improving retention through better working conditions and incentives, and deploying telemedicine and digital health solutions to extend reach.

Encourage Public-Private Partnerships (PPPs): Foster collaborations between the public and private sectors to leverage resources, expertise, and innovation in delivering healthcare services. PPPs can help bridge gaps in infrastructure and service delivery.

Promote Research and Development: Invest in medical research and development to foster innovation in treatments, diagnostics, and healthcare delivery models that are suited to India's specific healthcare challenges.

Focus on Preventive Healthcare: Shift focus towards preventive healthcare initiatives such as immunization programs, maternal and child health services, nutrition counseling, and lifestyle management to reduce the burden of preventable diseases.

Harness Technology: Leverage technology solutions such as telemedicine, electronic health records, mobile health apps, and artificial intelligence to improve healthcare access, efficiency, and patient outcomes, especially in remote and rural areas.

Improve Data Collection and Health Information Systems: Strengthen health information systems for better data collection, analysis, and decision-making. Data-driven policies can help allocate resources effectively and track healthcare outcomes.

Public Awareness and Education: Promote health literacy and awareness campaigns to empower individuals to make informed healthcare choices, adopt healthy behaviors, and seek timely medical care.

By implementing these strategies with a focus on equity, efficiency, and sustainability, India can make significant strides in improving its healthcare system to better meet the needs of its diverse population.

[simranmakhija1]

Insightful Guidance: Advancing Trends in the Second Opinion Market

The medical second opinion market is experiencing significant growth and transformation, driven by a variety of factors including technological advancements, increasing patient empowerment, and the growing demand for specialized healthcare services. As individuals become more proactive in managing their health and seeking out the best possible care, the need for reliable and accessible second opinions has become increasingly evident.

Get a free Sample: https://www.marketdigits.com/request/sample/4663

One of the primary drivers behind the growth of the medical second opinion market is the rise of telemedicine and digital health technologies. These technologies have made it easier for patients to connect with healthcare providers and specialists remotely, facilitating the exchange of medical records, diagnostic images, and other relevant information for review and consultation. Telemedicine platforms and virtual consultation services have enabled patients to seek second opinions from experts around the world, overcoming geographic barriers and improving access to specialized care.

In 2024, the Medical Second Opinion Market is valued at USD 5.49 billion and is projected to reach USD 16.50 billion by 2030, indicating a growth rate of 16.99% CAGR during the forecast period from 2024 to 2032.

Major players in the global Medical Second Opinion Market: HCA Hospitals, AXA PPP Healthcare, Royal London Group, Teladoc Health, Amradnet, Johns Hopkins Medicine, DoctorSpring, 2nd MD, SecondOpinionExpert, Inc. and Others.

Moreover, the focus on patient-centered care and shared decision-making has contributed to the increasing demand for medical second opinions. Patients are increasingly taking an active role in their healthcare decisions and seeking out multiple perspectives to ensure they receive accurate diagnoses and optimal treatment plans. Second opinions can provide patients with peace of mind, confidence in their treatment decisions, and reassurance that they are receiving the highest quality of care.

Additionally, the growing prevalence of chronic and complex medical conditions has fueled the demand for medical second opinions. For conditions such as cancer, heart disease, and neurological disorders, where treatment decisions can have significant implications for patient outcomes, seeking a second opinion is often recommended to confirm diagnoses, explore treatment options, and ensure personalized and evidence-based care.

Furthermore, the medical second opinion market is benefiting from increased collaboration and partnerships between healthcare providers, insurance companies, and telemedicine platforms. These collaborations facilitate the integration of second opinion services into existing healthcare systems, making them more accessible and affordable for patients. Additionally, some insurance companies offer coverage for second opinion consultations, further incentivizing patients to seek out this valuable service.

However, despite the numerous benefits and opportunities presented by the medical second opinion market, several challenges and considerations remain. These include concerns about data privacy and security, regulatory compliance, and reimbursement policies. Ensuring the confidentiality and integrity of patient information is paramount in telemedicine and second opinion services, requiring robust data protection measures and compliance with healthcare regulations such as HIPAA.

In conclusion, the medical second opinion market is experiencing rapid growth and evolution, driven by technological innovation, patient empowerment, and the growing complexity of healthcare. As the demand for specialized and personalized care continues to rise, the importance of medical second opinions as a valuable healthcare service will only continue to grow. By leveraging telemedicine, digital health technologies, and collaborative partnerships, the medical second opinion market has the potential to transform the way healthcare is delivered and improve patient outcomes worldwide.

[sandeep-health-care]

Make in India for the world

India’s leading in-vitro diagnostic company has been manufacturing and supplying diagnostic solutions for over 35 years now. Transasia Bio-Medicals Ltd., has fortified its presence, being recognised as India’s top manufacturer and exporter of diagnostic instruments and reagents in over 100 countries. Infact, Transasia is the first Indian company to manufacture and export sophisticated, state of the art blood analysers and reagents.

The Indian healthcare sector, one of its fastest growing industries, is expected to grow at a CAGR of 17 per cent to touch US$ 280 billion by 2020. Diagnostics forms an integral part of the healthcare sector as 70 per cent of the treatment decisions are based on lab results.

Over the past few years, In-Vitro Diagnostics market has been projecting substantial double digit growth. India, with its rich pool of resources, is being recognised as the next destination for establishing manufacturing set-ups.

Indian diagnostic industry –where we stand The last decade has been very progressive for the Indian healthcare industry. Rural areas have seen an increase in the number of primary healthcare setups. Health drives are regularly conducted; as a result the awareness amongst the people has gone up considerably. Emphasis is laid on early detection and precise treatment. In the urban areas, there has been a boom in the number of centres offering quality healthcare. The Government has encouraged the setting up of secondary and tertiary healthcare centres. Continuous technological advancements in diagnostics and an increased healthcare awareness have made in-vitro diagnostic testing an indispensable tool in current medical practices.

The increase in the diagnosis of chronic lifestyle and genetic diseases, ageing population, and rising acceptance of personalised medicine drive the in-vitro diagnostic market growth. Preventive healthcare is gaining popularity, due to growing health consciousness, improved spending power and increased life expectancy. The emerging industry structure is heading towards providing healthcare services as an integrated comprehensive package rather than the traditional concept of providing healthcare infrastructure and reactive medical care.

Moreover, even patients today are well read and are key decision makers in their treatment process. As a result, now there is greater onus on the diagnostic setups to provide precise and quick results. This in turn has made the diagnostic product manufacturing companies to offer their products at competitive rates.

Need for ‘Make in India’ There has been a paradigm shift resulting in adoption of technology and automation. The need for accurate and quick results has led to the introduction of high end products for in-depth analysis. A host of Indian companies today, have shifted base from importing to manufacturing.

Transasia Bio–Medicals Ltd. has pioneered ‘Make in India’ as it began ‘Making in India’ in 1991. Today, Transasia is the No. IVD company in India with subsidiaries in 11 countries and sales network in over 100 countries across the globe.

The Government is supporting Public-Private Partnerships (PPP) and other new initiatives for promoting the growth of the Indian IVD. The Government has encouraged Foreign Direct Investment (FDI) as well as indigenous research thereby promoting the sector. There has been a rise in the number of players entering the segment and offering quality products and after sales services.

Pool of skilled manpower has always been India’s forte. And there is no dearth in the Indian IVD Industry either.

Our fast-paced and stable economy is encouraging foreign and domestic players to increase the investment in healthcare infrastructure.

Today, the diagnostic business is mainly based on technology. The drive or thrust for smaller, faster and easily accessible devices is increasing. Emerging markets have different needs with respect to test menus, technologies and operating procedures. Thus customised solutions need to be developed depending on the need. Indian companies with their R&D facilities have developed a range of good quality products for the local market amidst fierce competition.

Deterrents to Indigenous Technology Today, the market is flooded with analysers from China, offering their services at cheap rates. The brain drain to the West acts as the biggest deterrent to promoting indigenous research and development. It is also difficult to change the mindset of clinicians to accept the ‘Made in India’ tag. Moreover, certain government policies need to be revisited to promote indigenous production.

Boost to innovation Despite the Government introducing a host of policies for in-house production, there is still scope for more. The government and private players need to join hands to promote innovation at reasonable prices. The Government needs to initiate policies to encourage indigenous manufacturing. This can be done through availability of funds, land demarked for setting up manufacturing units, tax relaxation, encouraging research & development, etc.

Encouraging foreign players to set up manufacturing units in India can help further.

Indigenous manufacturing of medical equipments –Where we stand today Indigenous manufacturing is picking up pace. At one point in time, the ratio of indigenous manufacturing to imports was just 5 per cent. However, tables have turned today. A lot many companies are now involved with in-house manufacturing. Indian companies have been manufacturing kits for blood grouping, serology, clinical chemistry, pregnancy detection, HIV detection and other rapid tests that are accepted globally. Today, imports of such products are negligible in finished form.

Transasia Bio-Medicals Ltd. - Local for global India’s leading in-vitro diagnostic company has been manufacturing and supplying diagnostic solutions for over 35 years now. Transasia Bio–Medicals Ltd., has fortified its presence, being recognised as India’s top manufacturer and exporter of diagnostic instruments and reagents in over 100 countries. Infact, Transasia is the first Indian company to manufacture and export sophisticated, state of the art blood analyzers and reagents.

Transasia started off, with marketing and after-sales service of a Japanese blood cell counter. It was during 1980s-90s, the machines were relatively expensive and affordable by only top hospitals. That is when Transasia started manufacturing them indigenously. The biggest challenge at that time was to counter the competition pouring in from the West. European and American manufactured products were widely accepted, because of their accuracy. So, it did take some time to prove the credibility of the indigenous instruments.

And today, Transasia is recognised as India’s Leading In-vitro Diagnostic Company. It has an installation base of over 45,000 instruments across India with a vast network of more than 150 service engineers, 350+ sales and marketing team, 14 zonal offices, and 350+ distributors.

Read More: https://www.europeanhhm.com/diagnostics/make-in-india-for-the-world

[healthkenya7]

ENGAGEMENT MECHANISMS TO AID QUALITY OF HEALTHCARE IN KENYA

According to Mr. Jayesh Saini, “To aid the quality of healthcare in Kenya, it is crucial to implement effective engagement mechanisms that involve the various stakeholders.”

Here are some engagement mechanisms that can help improve healthcare quality in Kenya:

Patient Engagement: Empowering patients and involving them in their own healthcare decisions is essential. This can be achieved through patient education programs, providing clear and understandable information about their health conditions, treatment options, and encouraging them to actively participate in their care plans. Engaging patients can also involve collecting feedback and suggestions through surveys or patient satisfaction assessments to identify areas of improvement.

Community Engagement: Engaging the local community is vital for promoting better healthcare outcomes. Community health workers can be trained and deployed to educate community members on preventive healthcare measures, disease management, and the importance of regular health check-ups. Community health forums, awareness campaigns, and outreach programs can be organized to foster community involvement and encourage healthy behaviors.

Healthcare Provider Engagement: It is essential to engage healthcare providers, including doctors, nurses, and other healthcare professionals, in quality improvement initiatives. This can be achieved through continuous medical education programs, workshops, and conferences that focus on evidence-based practices, clinical guidelines, and emerging healthcare trends. Collaboration platforms, such as medical societies and online forums, can be established to facilitate knowledge sharing, peer support, and learning opportunities.

Government Engagement: The government plays a critical role in improving healthcare quality. Engaging policymakers and healthcare regulators can help shape policies and regulations that prioritize quality improvement. Collaboration between the government and healthcare institutions can lead to the development and implementation of national quality standards, accreditation programs, and monitoring systems to ensure adherence to quality benchmarks.

Public-Private Partnerships (PPPs): Engaging the private sector through PPPs can leverage additional resources and expertise to enhance healthcare quality. Collaborations between public and private healthcare providers can lead to improved infrastructure, technology adoption, and service delivery. PPPs can also promote knowledge exchange and innovation, fostering a culture of quality improvement.

Data and Information Sharing: Establishing robust health information systems and data-sharing platforms is crucial for measuring and monitoring healthcare quality. Engaging healthcare providers in data collection, analysis, and reporting can help identify gaps, track progress, and inform evidence-based decision-making. Transparent reporting of quality indicators can drive accountability and facilitate benchmarking.

Continuous Quality Improvement (CQI): Implementing CQI methodologies, such as Plan-Do-Study-Act (PDSA) cycles, can engage healthcare teams in systematic problem-solving and process improvement. Encouraging frontline staff to actively participate in identifying and addressing quality gaps can lead to more efficient and effective healthcare practices.

Mr. Jayesh commented that: “The successful engagement of these mechanisms will require strong leadership, effective communication, and a commitment to collaboration among all stakeholders involved in the healthcare system in Kenya. This will ensure the success of quality healthcare provision, both now and in the future.”

#jayeshsaini #healthcare #LifeCareHospitals #Kenya #NHIF #NPS #TSC

[sillyruinsdaze]

N. Chandrababu Naidu’s And TDP's Impact on Healthcare in Andhra Pradesh

When it comes to healthcare in Andhra Pradesh, the Telugu Desam Party (TDP) and its visionary leader, N. Chandrababu Naidu, have made significant TDP Contributions. Under his leadership, the former TDP government implemented several transformative initiatives aimed at improving the quality and accessibility of healthcare services across the state. There are several key contributions of the former TDP government and N. Chandrababu Naidu to the healthcare sector in Andhra Pradesh. Recognizing the need for robust healthcare infrastructure, the former TDP government, led by N. Chandrababu Naidu, embarked on the TDP Agenda and an ambitious mission to develop state-of-the-art medical facilities. Several multi-speciality hospitals, including the prestigious NTR Health University, were established across the state. These institutions were equipped with advanced medical technologies and skilled healthcare professionals, ensuring high-quality healthcare services for the people of Andhra Pradesh.

The former TDP government introduced significant health reforms to enhance the efficiency and effectiveness of healthcare delivery. One of the notable TDP Schemes was the launch of the Health Schemes, a comprehensive health insurance program aimed at providing financial protection to the economically vulnerable sections of society. This TDP Policy facilitated access to advanced medical treatments for critical illnesses, reducing the burden of healthcare expenses on families. Under N. Chandrababu Naidu's leadership, the TDP government emphasized the importance of preventive healthcare. The state witnessed the implementation of various awareness campaigns and health education programs to educate citizens about the significance of leading a healthy lifestyle, early disease detection, and vaccination drives. This proactive approach helped in reducing the prevalence of preventable diseases and promoting overall well-being among the population.

Recognizing the disparity in healthcare access between urban and rural areas, the TDP government prioritized the development of rural healthcare infrastructure. N Chandrababu Naidu's administration established primary health centres and mobile medical units in remote regions, ensuring that even the most underserved communities had access to basic healthcare services. These TDP Policies played a crucial role in bridging the healthcare divide and improving health outcomes in rural Andhra Pradesh. Realizing the need for collaborative efforts in healthcare, N. Chandrababu Naidu's TDP government actively encouraged public-private partnerships (PPPs). By involving private players in healthcare service delivery, the TDP Political Leaders through their efforts expanded the reach and scope of healthcare services in the state. This approach facilitated the sharing of expertise, resources, and technology, ultimately benefiting the people of Andhra Pradesh.

The former TDP government, under N Chandrababu Naidu's leadership, focused on strengthening medical education and research in Andhra Pradesh. Several medical colleges were established, providing quality education and training to aspiring healthcare professionals. Additionally, research institutions were set up to promote scientific inquiry and innovation in healthcare. These TDP Achievements not only fostered the growth of the healthcare sector but also contributed to the overall development of the state. The TDP Party, under the leadership of N. Chandrababu Naidu, has made significant TDP Developments in the healthcare sector in Andhra Pradesh. From infrastructure development to health reforms, and preventive healthcare initiatives to rural healthcare improvement, the TDP's efforts have positively impacted the lives of millions of people. By prioritizing the well-being of its citizens and embracing innovation and collaboration, the TDP government has set a commendable example for healthcare governance in the state. Click through the official website for Recent news and local news and also for the contributions made by N. Chandrababu Naidu for a  healthier and prosperous Andhra Pradesh.

[ananya5400]

Key Trends Shaping the Rodenticides Market

The global rodenticides market is estimated to be valued at USD 5.3 billion in 2022. It is projected to reach USD 7.1 billion by 2027, recording a CAGR of 5.8% during the forecast period. The rodenticides market is driven by rapid urbanization across regions. The increase in awareness on public hygiene, the prevention of vector-borne diseases, and the rise in purchasing power parity (PPP) among the middle-class population are factors that have encouraged the demand for pest control services, globally. In addition, government initiatives for maintaining environmental hygiene are projected to drive the demand for rodenticides. For instance, the “clean-up” movement in India has proven to be a major driver for the insect pest control industry.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189089498

Increase in the global trade of rodenticides

Germany is one of the global leaders engaged in the export of rodenticides. It is followed by India, the US, the UK, Belgium, and Italy. Germany has a presence of major chemical companies, such as Bayer AG and BASF SE, which have a wide portfolio of insect pest control products. The country is a major exporter of rodenticides to countries, such as the Netherlands, the UK, and France. These countries import rodenticides due to their high-quality standards, fewer transportation costs, and easy accessibility. India is emerging as a potential export hub for high-quality rodenticides due to low-cost manufacturing and the security of patented new active ingredients. India majorly exports rodenticides to countries, such as Brazil, the US, and the Netherlands. China is a dominant exporter of rodenticides to Southeast Asian countries, such as Vietnam, Thailand, and Indonesia. This increase in demand for rodenticides across the globe is attributed to factors, such as government initiatives for health awareness programs, an increase in crop losses, and a rise in health concerns due to rodent attacks.

Sprays are Permitted for use only by Professional Pest Applicators

Most fumigants include phosphide compounds, such as zinc and aluminum phosphides. Bromides are also used for rodent treatment in a few countries. Carbon dioxide is also used as a fumigant against commensal mice. Fumigants or rodenticides in the spray form are used in warehouses, along with minimal use in agricultural fields. Sprays cannot be used in urban areas because they cause health concerns in humans and other non-target animals. Fumigants are used for destroying rodent burrows through gassing. It involves the insertion of either pellets or tablets in the rodent burrow, which are then sealed with soil. The gases evolved to build up to concentrations that are lethal to the rodents occupying the burrows.

North America and Asia Pacific are the major exporters of crops across the globe. High quantities of grains are stored in warehouses, and fumigants, are majorly used in these warehouses for rodent control. In addition, sprays of zinc phosphide are used against mouse plagues in Australia.

Request for Sample Pages of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=189089498

Asia Pacific is expected to be the fastest-growing region with a CAGR of 6.5% during the forecast period.

The Asia Pacific market is completely driven by the country markets of China, India, Japan, Australia, Thailand, Indonesia and few other Asian counties. As the world’s largest and most populous region, Asia Pacific is one of the key markets for rodenticides. Rodents are common pests present in agricultural fields. Annually, extensive volumes of agricultural produce are destroyed and contaminated by rodents. To meet the increase in demand for food products and to reduce the crop damages caused by rodents, the use of rodenticides has increased significantly in the region. The food retail, food manufacturing, pharmaceutical, hospitality, and residential sectors are expected to be major growth verticals in this market.Asia Pacific is expected to be the fastest-growing region during the forecast period due to several reasons. One of the major drivers of the market is the fact that agriculture is one of the most significant revenue-generating sectors in China and India. The growing population within the region is urging the farmers to provide a maximum yield to fulfill the demand of the increasing population. In such cases, the increasing crop damage and decreasing food production due to rodents are expected to leverage this market positively.

Key players in this market include Basf Se(Germany), Bayer Ag(Germany), Syngenta Ag(Switzerland), UPL Limited(India) Neogen Corporation(US)

[badralsamaa]

The conference on public private collaboration for disease control was conducted by MoH under the auspices of Badr Al Samaa Group of Hospitals. It was attended by Dr. Mazin Khabouri, DG Private Health Establishments, Dr Seif Al-Abri, DG, Directorate General for Disease Surveillance and Control (DGDSC) and many senior ministry official and strong representation by Private Healthcare Establishments. In multiple presentations PPP was discussed and emphasis was put on the important and integral role of Private Players in diagnosis, treatment and elimination of communicable diseases like TB, HIV, etc.  

[imaec-digital]

Different schemes extended by the government for renal care

An Overview of dialysis care in India:

In India, the number of fatalities caused by CKD increased from 0.59 million in 1990 to 1.18 million in 2016. Because there are no renal failure registries, data on the incidence and prevalence of kidney failure must be inferred. According to the Million Death Study, 136,000 people died of renal failure in 2015. According to a 2018 estimate, India’s chronic dialysis patients number 175,000, with a frequency of 129 per million people. Dialysis is quickly expanding in India, yet there is still space to increase access and service quality. Scaling up service delivery is an attainable aim with commitment from the federal Union and state governments, as well as the addition of additional service providers. In addition to the National Dialysis Scheme, administered through designated district-level centres, eligible patients can receive dialysis at other hospitals reimbursed under the National Health Protection Scheme (launched in 2018), which was later renamed Ayushman Bharat Pradhan Mantri Jan Arogya Yojana(1).

Pradhan Mantri National Dialysis Programme:

End-stage renal disease is still a result of the present and rising non-communicable disease burden. Patients require long-term care, which includes operations that use a lot of resources, such as dialysis. The Pradhan Mantri National Dialysis Program (PMNDP) aims to enhance District Hospitals by making dialysis treatments more affordable. To make use of the private sector’s capability in the dialysis care segment, the Dialysis Program is run as a Public-Private Partnership in some states, with certain states having their own in-house service delivery system. Following is the optimum and cost-effective strategy, as determined by collaboration with experts and discussions with some of the states implementing the Dialysis program in the PPP manner.

A) It is desirable to spread out dialysis services across the states, starting with District Hospitals in a public-private partnership. Direct provisioning by state governments would be time-consuming, expensive, and dangerous.

B) The service provider shall supply medical personnel, dialysis equipment, as well as the infrastructure for a RO water plant, a dialyzer, and consumables.

C) The payer government should provide space at district hospitals, drugs, electricity, and water, as well as pay for dialysis for impoverished patients.

Pradhan Mantri Jan Arogya Yojana- Ayushman Bharat (PMJAY-AB):

PMJAY-AB is a government of India-run national public health insurance fund that intends to provide low-income Indians with free health insurance coverage. This programme benefits around half of the country’s population. PMJAY is Ayushman Bharat’s tertiary care arm, through which qualified families are given a Rs 5 lakh yearly health cover. Under PMJAY, any empanelled government or private institution receives Rs 2,000 every haemodialysis session. Chhattisgarh, Gujarat, and Maharashtra are the states with the most claims, with 4,68,438, 3,33,883, and 2,98,208 claims, respectively. Dialysis has emerged as the most popular package under the Pradhan Mantri Jan Arogya Yojana (PMJAY) nine months after its launch. Despite the fact that the Pradhan Mantri National Dialysis Programme, which began in 2016, offers free dialysis to renal patients at district hospitals, this remains the case. The growing number of applicants under PMJAY demonstrates India’s high prevalence of hypertension and renal disease.(3)

Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY):

Jyotirao Pule, Mahatma Jyotirao The Maharashtra government’s major health insurance plan is the Jan Arogya Yojana. Through a network of government and private sector service providers, the initiative delivers end-to-end cashless services for designated conditions. The initiative was previously known as the Rajiv Gandhi Jeevandayee Arogya Yojana, and it began on July 2, 2012, in eight districts before being expanded to 28 districts in Maharashtra on November 21, 2013. In Maharashtra, the AB-PMJAY was introduced in collaboration with Mahatma Jyotirao Phule Jan Arogya Yojna and was executed in a combined insurance and assurance mode. The Ayushman Bharat-Pradhan Mantri Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY) and the Integrated Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY) On April 1, 2020, the state’s Jan Arogya Yojana (AB-PMJAY) was inaugurated.

Under the insurance mode, United India Insurance Company Limited (Public Sector Undertaking Company) offers health insurance coverage to beneficiaries, while the assurance method is provided by the State Health Assurance Society. The State Health Assurance Society pays the Insurance Company an annual insurance premium of 797/- per family in quarterly instalments on behalf of qualified beneficiary households. Mahatma Jyotirao Phule Jan Arogya Yojana is fully funded by the Government of Maharashtra. Pradhan Mantri Jan Arogya Yojana is jointly funded by the Government of India and the Government of Maharashtra in a ratio of 60:40(2).

[researchvishal]

Antibiotic Susceptibility Testing Market Potential Growth, Demand And Analysis Of Key Players - Analysis Forecasts To 2028

A recently published research intelligence on the global antibiotic susceptibility testing market size by Future Market Insights tracks the top five influencers pushing demand and revenue growth of the market at a global level.

Infectious diseases, prevailing at a high pace

Increasing rate and tenure of hospitalization

Growing significance of early diagnostics

Soaring research interests in microbial susceptibility testing

Improving funding scenario for research, driven by governments & private bodies

Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Bn by 2028, expanding at a CAGR of 5.2%

Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST).

Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market.

CDC’s ‘AMR Challenge’ involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of microbial resistance.

Request Sample PDF Brochure:

Research in Screening of High Pathogen Concentration Samples to Propel Demand for AST

The process of spotting a specific set of genes responsible for antibiotic resistance is highly complicated when it comes to handling the complexities associated with samples that have high concentration of pathogens.

Some of the highly desirable antibiotic susceptibility testing systems that allow direct-from-sample pathogen identification through high pathogen concentration samples, are thus likely to gain high traction in coming years.

Growing research efforts in the recognition of the presence of a specific set of antibiotic resistant genes can direct efforts for identification and selection of narrow-spectrum antibiotics, which remains among the most prominent factors pushing installed base of such antibiotic susceptibility testing equipment.

A few recent launches in this segment include Genmark Diagnostics’ ePLEX Blood Culture ID Panel, Biomerieux’s BioFire FilmArray, and Luminex Corp.’s Verigene Bloodstream Infection Panel.

The report also sheds light on the increasing role of Ecommerce in the market by boosting the availability of antibiotic susceptibility testing systems. Offering improved access to susceptibility testing devices by industry’s leading brands, online retail operators have been attracting prominent vendors in the global antibiotic susceptibility testing market.

A number of vendors dealing in antibiotic susceptibility testing equipment are opting for devices that are available online owing to the significantly reduced costs and additional discounts on price.

Entry of Technologically Advanced AST Systems to Favor Market Growth

As indicated by research, the sales of antibiotic susceptibility testing equipment will witness healthy growth owing to increasing demand for specific susceptibility testing systems to define the scope of targeted therapy.

Targeting key pathogens is imperative to design a highly specific plan of treatment for a particular patient, and antibiotic susceptibility testing systems efficiently allow researchers to achieve it within a significantly short timeline.

With FDA approving a considerable number of antibiotic and microbial susceptibility testing equipment, especially in the recent past, FMI forecasts an impressive installed base for antibiotic susceptibility testing systems in coming years.

Advanced technology enabled antibiotic susceptibility testing equipment allows early diagnosis that in turn improves chances of developing targeted therapy earlier. One such recent advancement enjoying visibly growing traction in market includes oCelloScope.

This antibiotic susceptibility testing equipment by BioSense Solutions is an optical susceptibility screening system with the capability to deliver real-time, time-lapse imaging of multiple microbial combinations, simultaneously.

Recently, Thermo Fisher Scientific, Inc. and Becton, Dickinson and Company received FDA approvals for their new launches in antibiotic susceptibility testing space. Moreover, FDA passed an approval to a susceptibility testing device by bioMérieux that has an expanded capability to identify a particular pathogen.

Market segmentation

Antibiotic Susceptibility Testing Market by Product:

Instruments

Automated Broth Microdilution Systems

Manual Broth Microdilution Systems

Semi-automated Broth Microdilution Systems

Software & Services

Image & Analysis Software

Installation Services

Kits & Reagents

Antibiotic Susceptibility Testing Market by Application:

Sepsis

Respiratory Infections

Gastrointestinal Infections

Meningitis & Encephalitis

Endocarditis

Others

Antibiotic Susceptibility Testing Market by End User:

Diagnostic Laboratories

Hospitals

Research Laboratories

[kara-patili-kedi]

" https://youtu.be/f98L-w4NQe0 https://www.youtube.com/channel/UCwzY0xO4dMr3DoZlQmI7Mow/ " https://4yourtubeview.blogspot.com/2018/08/pearly-papules-ppp-removal-at-home.html

[sweetreena]

I found this https://youtu.be/f98L-w4NQe0 https://www.youtube.com/channel/UCwzY0xO4dMr3DoZlQmI7Mow/ from http://syndicator.myimplace.com/pearly-papules-ppp-removal-at-home-treating-papules-ppp-disease-treatment-getting-rid-of-papules/ right here: https://bardzofajnewideo.blogspot.com/2018/08/pearly-papules-ppp-removal-at-home.html

[uberclanger]

https://youtu.be/f98L-w4NQe0 https://www.youtube.com/channel/UCwzY0xO4dMr3DoZlQmI7Mow/ pearly papules, ppp removal at home, treating papules, ppp disease treatment, getting rid of papules via http://syndicator.myimplace.com/pearly-papules-ppp-removal-at-home-treating-papules-ppp-disease-treatment-getting-rid-of-papules/ approved by https://www.google.com

[wumblr]

They have been shut out by the prohibitive cost and by wealthy nations who bought up most of the available doses

there is no prohibitive cost, as JYNNEOS costs $29 to produce and $115 to administer, and ACAM2000 costs $5 to produce and $135 to administer, or $144 vs $140

it would cost $864b to vaccinate 6 billion people, which is less than the PPP loan program cost, and we've already got something like 100m or 250m ACAM2000 doses collecting dust in storage

what we have is a shortage of political will in america to take responsibility for the cost. we don't lack money, we don't lack resources, we don't lack production capacity, and we already have a substantial stockpile going unused

the government continues to refuse to publish precise numbers on the ACAM2000 stockpile. 270m have been produced over 20 years, some portion of that remains unexpired. the other portion of it expired for strategic defense while it could have been used for eradication. that ought to be a crime

There are limits on transparency with data about vaccine and treatment stockpiles, which are considered national security issues, and access to the biomedical interventions is controlled by defense experts rather than public health ones.

a war empire has nothing else

[newstfionline]

Headlines

Exhausted cities face another challenge: a surge in violence (AP) Still reeling from the coronavirus pandemic and street protests over the police killing of George Floyd, exhausted cities around the nation are facing yet another challenge: a surge in shootings that has left dozens dead, including young children. The spike defies easy explanation, experts say, pointing to the toxic mix of issues facing America in 2020: an unemployment rate not seen in a generation, a pandemic that has killed more than 130,000 people, stay-at-home orders, rising anger over police brutality, intense stress, even the weather. “I think it’s just a perfect storm of distress in America,” said Atlanta Mayor Keisha Lance Bottoms after a weekend of bloodshed in her city. Jerry Ratcliffe, a Temple University criminal justice professor and host of the “Reducing Crime” podcast, put it more bluntly: “Anybody who thinks they can disentangle all of this probably doesn’t know what they’re talking about.” Through Sunday, shootings in New York City were up more than 53%—to 585—so far this year. In Dallas, violent crime increased more than 14% from April to June. In Philadelphia, homicides were up 20% for the week ending July 5 over last year at this time. In Atlanta, 31 people were shot over the weekend, five fatally, compared with seven shootings and one killing over the same week in 2019.

Congress created virus aid, then reaped the benefits (AP) At least a dozen lawmakers have ties to organizations that received federal coronavirus aid, according to newly released government data, highlighting how Washington insiders were both author and beneficiary of one of the biggest government programs in U.S. history. Under pressure from Congress and outside groups, the Trump administration this week disclosed the names of some loan recipients in the $659 billion Paycheck Protection Program, launched in April to help smaller businesses keep Americans employed during the pandemic. Connections to lawmakers, and the organizations that work to influence them, were quickly apparent. Members of Congress and their families are not barred from receiving loans under the PPP, and there is no evidence they received special treatment. Hundreds of millions of dollars also flowed to political consultants, opposition research shops, law firms, advocacy organizations and trade associations whose work is based around influencing government and politics. While voting, lobbying and ultimately benefiting from legislation aren’t illegal, advocates say the blurred lines risk eroding public trust in the federal pandemic response. “It certainly looks bad and smells bad,” said Aaron Scherb, a spokesperson for Common Cause, a watchdog group that was also approved for a loan through the program.

Missouri summer camp virus outbreak raises safety questions (AP) Missouri leaders knew the risk of convening thousands of kids at summer camps across the state during a pandemic, the state’s top health official said, and insisted that camp organizers have plans in place to keep an outbreak from happening. The outbreak happened anyway. An overnight summer camp in rural southwestern Missouri has seen scores of campers, counselors and staff infected with the coronavirus, the local health department revealed this week, raising questions about the ability to keep kids safe at what is a rite of childhood for many. The Kanakuk camp near Branson ended up sending its teenage campers home. On Friday, the local health department announced 49 positive cases of the COVID-19 virus at the camp. By Monday, the number had jumped to 82.

Our Cash-Free Future Is Getting Closer (NYT) PARIS—On a typical Sunday, patrons at Julien Cornu’s cheese shop used to load up on Camembert and chèvre for the week, with about half the customers digging into their pockets for euro notes and coins. But in the era of the coronavirus, cash is no longer à la mode at La Fromagerie, as social distancing requirements and concerns over hygiene prompt nearly everyone who walks through his door to pay with plastic. “People are using cards and contactless payments because they don’t want to have to touch anything,” said Mr. Cornu, as a line of mask-wearing shoppers stood three feet apart before approaching the register and swiping contactless cards over a reader. While cash is still accepted, even older shoppers—his toughest clientele when it comes to adopting digital habits—are voluntarily making the switch. Cash was already being edged out in many countries as urban consumers paid increasingly with apps and cards for even the smallest purchases. But the coronavirus is accelerating a shift toward a cashless future. Fears over transmission of the disease have compelled consumers to rethink how they shop and pay.

The White House and AMLO (Foreign Policy) Mexican President Andrés Manuel López Obrador visits the White House today (Wednesday) for his first foreign trip since winning the presidency in 2018. His arrival in Washington on Tuesday evening was typically on-brand for the leftist leader: He flew in economy class on a commercial airliner (albeit in an exit row). Unlike Canadian Prime Minister Justin Trudeau—who spurned an invite to today’s meeting as the U.S. government threatens to place tariffs on Canadian aluminum—this summit is too good an opportunity for López Obrador to turn down. That’s largely because of the importance of the United States to Mexico’s economy—which is predicted to contract by 10.5 percent this year, according to the International Monetary Fund. As his approval rating gradually falls along with Mexico’s economic performance, López Obrador is aiming to stay on Trump’s good side. “This is about the economy, it’s about jobs, it’s about well-being,” López Obrador said before he departed for Washington.

Berlin looks east (Foreign Policy) Germany is hoping to strengthen its economic ties with China, setting itself apart from the rest of the West and the United States in particular. Germany’s relationship with China has always been divided. On one hand, human rights issues preoccupy the German public, and figures such as Ai Weiwei and Liao Yiwu are well known there. But on the other, trade between China and Germany is significant and largely responsible for Germany’s post-2008 prosperity. The antagonism shown by President Donald Trump and his team toward German Chancellor Angela Merkel has also poisoned any attempts by the United States to sell Berlin on a split with Beijing.

OECD unemployment rate to hit record highs (Foreign Policy) The world’s wealthiest countries will see record unemployment rates as a result of the coronavirus pandemic, according to the Organization for Economic Cooperation and Development (OECD). The OECD forecast a 9.4 percent unemployment rate across the 37 countries that make up the group’s membership, a number that could go as high as 12.6 percent if these countries see a second wave of coronavirus cases. In releasing the data, OECD Secretary-General Angel Gurría called on wealthy countries to better protect the economically vulnerable across their societies. “In times of crisis, ‘normality’ sounds very appealing. However, our normal was not good enough for the many people with no or precarious jobs, bad working conditions, income insecurity, and limits on their ambitions,” Gurría said.

Rioting in Serbia (Reuters) Dozens of demonstrators and police were injured in overnight rioting in Belgrade, triggered when a crowd stormed Serbia’s parliament in protest at plans to reimpose a lockdown following a surge in coronavirus cases. Footage showed police kicking and beating people with truncheons while protesters pelted officers with stones and bottles, after thousands chanting for the resignation of President Aleksandar Vucic gathered outside the building. Vucic announced the new lockdown on Tuesday, saying it was needed because of the rising number of coronavirus cases.

Top U.S. general speaks on Russian bounty case (Foreign Policy) Gen. Frank McKenzie, the head of U.S. Central Command, has poured cold water on recent allegations, first reported by the New York Times, of a program run by Russian intelligence offering cash to Afghan militants for killing U.S. soldiers. McKenzie called the reports “very worrisome,” but said he couldn’t point to any U.S. casualties that could have had a direct link to the alleged program. McKenzie said that Russia’s actions in Afghanistan should, however, still be watched closely.

Japan battered by more heavy rain, floods; 58 dead (AP) Pounding rain that already caused deadly floods in southern Japan was moving northeast Wednesday, battering large areas of Japan’s main island, swelling more rivers, triggering mudslides and destroying houses and roads. At least 58 people died in several days of flooding. Parts of Nagano and Gifu, including areas known for scenic mountain trails and hot springs, were flooded by massive downpours.

‘We’re next’: Hong Kong security law sends chills through Taiwan (AFP) The imposition of a sweeping national security law on Hong Kong has sent chills through Taiwan, deepening fears that Beijing will focus next on seizing the democratic self-ruled island. China and Taiwan split in 1949 after nationalist forces lost a civil war to Mao Zedong’s communists, fleeing to the island which Beijing has since vowed to seize one day, by force if necessary. Over the years China has used a mixture of threats and inducements, including a promise Taiwan could have the “One Country, Two Systems” model that governs Hong Kong, supposedly guaranteeing key civil liberties and a degree of autonomy for 50 years after the city’s 1997 handover. Both Taiwan’s two largest political parties long ago rejected the offer, and the new security law has incinerated what little remaining faith many Taiwanese may have had in Beijing’s outreach. Some now fear even transiting through Hong Kong, worried that their social media profiles could see them open to prosecution under the legislation.

Millions of Australians brace for lockdowns amid Melbourne virus outbreak (Reuters) Five million Australians face a heavy police clampdown from midnight on Wednesday to contain a flare-up of coronavirus cases, with checkpoints to be set up around Melbourne to ensure people stay at home.

Suleimani killing “unlawful” (Foreign Policy) In a new report, Agnès Callamard, the U.N. special rapporteur on extrajudicial, summary or arbitrary executions, concluded that the January killing of Iranian Commander Qassem Suleimani by a U.S. drone strike was arbitrary and unlawful under international human rights law, citing a lack of any imminent threat posed by Suleimani in the lead up to the assassination. Callamard will present her findings to the U.N. Human Rights Council on Thursday. The United States left the council in 2018.

Rising food prices in Lebanon (Worldcrunch) In Lebanon, the constant change of the dollar exchange rate and a plummeting Lebanese pound have led to a 190% increase in food prices within a year. Hit with exponential inflation, French daily Les Echos notes that the country is facing its most serious economic and currency crisis since the end of its 1975-1990 civil war.

Dozen of bodies found in Burkina Faso, and rights group suspects extrajudicial killings (Reuters) At least 180 bodies have been found in common graves in Djibo, a town in the north of Burkina Faso, Human Rights Watch (HRW), said in a report released on Wednesday, saying that the killings were likely carried out by government forces.

[sillyruinsdaze]

Strengthening Public Healthcare: N Chandrababu Naidu's Focus on Enhancing Healthcare Infrastructure and Services for Public Welfare in Andhra Pradesh

Healthcare is a fundamental right of every citizen, and a robust public healthcare system plays a vital role in ensuring access to quality medical services. Recognizing this, N Chandrababu Naidu, the former Chief Minister of Andhra Pradesh, prioritized the enhancement of healthcare infrastructure and services to uplift the public welfare in the state. With a vision to provide affordable and accessible healthcare to all, his government implemented several initiatives that aimed to strengthen the public healthcare system in Andhra Pradesh. Delve into the TDP website for more initiatives and contributions of N Chandrababu Naidu.

Under N Chandrababu Naidu's leadership, there was a strong focus on expanding healthcare infrastructure across the state. The government invested in the construction of new hospitals, upgrading existing healthcare facilities, and establishing specialized medical centres. This expansion aimed to bridge the gap between urban and rural healthcare facilities, ensuring that people from all regions had access to quality medical services.

Recent news states that several multi-speciality hospitals were set up in different districts, equipped with state-of-the-art infrastructure and advanced medical equipment. These hospitals catered to various medical needs, ranging from primary care to specialized treatments. Additionally, the TDP government established tertiary care centres and super-speciality hospitals to provide advanced medical interventions and treatments to patients.

Recognizing the importance of primary healthcare in preventing and managing diseases, TDP's government took significant steps to revamp the primary healthcare system in Andhra Pradesh. The main agenda of N Chandrababu Naidu was to focus on strengthening primary health centres (PHCs) and sub-centres, ensuring their efficient functioning and availability of basic healthcare services.

Efforts were made to address the shortage of healthcare professionals in rural areas by recruiting and deploying additional medical staff, including doctors, nurses, and paramedical personnel. This not only improved the quality of healthcare services but also reduced the burden on tertiary care facilities by promoting early detection and management of diseases at the primary level.

Timely access to emergency medical services can be crucial in saving lives. The Telugu Desam Political Party government under his leadership recognized this and emphasized the development of emergency medical services (EMS) in Andhra Pradesh. The TDP government established a comprehensive EMS network across the state, equipped with ambulances, trained paramedics, and emergency response systems.

The EMS network ensured that critical patients could receive immediate medical attention and be safely transported to the nearest healthcare facility. The ambulances were equipped with life-saving equipment and had connectivity to hospitals for real-time communication and coordination. This initiative significantly reduced response times and improved outcomes in emergency situations.

To further strengthen the public healthcare system, N Chandrababu Naidu's government encouraged public-private partnerships (PPPs) in healthcare delivery. This collaboration aimed to leverage the expertise and resources of the private sector while ensuring the provision of affordable and quality healthcare services to the public.

Several PPP initiatives were undertaken, such as the establishment of private medical colleges in underserved areas, outsourcing diagnostic services to private laboratories, and partnering with private hospitals to provide specialized treatments. These collaborations not only enhanced the availability of healthcare services but also promoted innovation and efficiency in service delivery. These achievements of TDP show the commitment of NCBN towards public healthcare. 

N Chandrababu Naidu's focus on enhancing healthcare infrastructure and services in Andhra Pradesh demonstrates his commitment to improving public welfare through accessible and affordable healthcare. The expansion of healthcare infrastructure, revamping of primary healthcare, development of emergency medical services, and promotion of public-private partnerships have collectively strengthened the public healthcare system in the state. These initiatives have paved the way for a healthier and more prosperous Andhra Pradesh, ensuring that its citizens have access to quality medical services when they need them the most.

[ananya5400]

Key Trends Shaping the Rodenticides Market

The global rodenticides market is estimated to be valued at USD 5.3 billion in 2022. It is projected to reach USD 7.1 billion by 2027, recording a CAGR of 5.8% during the forecast period. The rodenticides market is driven by rapid urbanization across regions. The increase in awareness on public hygiene, the prevention of vector-borne diseases, and the rise in purchasing power parity (PPP) among the middle-class population are factors that have encouraged the demand for pest control services, globally. In addition, government initiatives for maintaining environmental hygiene are projected to drive the demand for rodenticides. For instance, the “clean-up” movement in India has proven to be a major driver for the insect pest control industry.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189089498

Increase in the global trade of rodenticides

Germany is one of the global leaders engaged in the export of rodenticides. It is followed by India, the US, the UK, Belgium, and Italy. Germany has a presence of major chemical companies, such as Bayer AG and BASF SE, which have a wide portfolio of insect pest control products. The country is a major exporter of rodenticides to countries, such as the Netherlands, the UK, and France. These countries import rodenticides due to their high-quality standards, fewer transportation costs, and easy accessibility. India is emerging as a potential export hub for high-quality rodenticides due to low-cost manufacturing and the security of patented new active ingredients. India majorly exports rodenticides to countries, such as Brazil, the US, and the Netherlands. China is a dominant exporter of rodenticides to Southeast Asian countries, such as Vietnam, Thailand, and Indonesia. This increase in demand for rodenticides across the globe is attributed to factors, such as government initiatives for health awareness programs, an increase in crop losses, and a rise in health concerns due to rodent attacks.

Sprays are Permitted for use only by Professional Pest Applicators

Most fumigants include phosphide compounds, such as zinc and aluminum phosphides. Bromides are also used for rodent treatment in a few countries. Carbon dioxide is also used as a fumigant against commensal mice. Fumigants or rodenticides in the spray form are used in warehouses, along with minimal use in agricultural fields. Sprays cannot be used in urban areas because they cause health concerns in humans and other non-target animals. Fumigants are used for destroying rodent burrows through gassing. It involves the insertion of either pellets or tablets in the rodent burrow, which are then sealed with soil. The gases evolved to build up to concentrations that are lethal to the rodents occupying the burrows

North America and Asia Pacific are the major exporters of crops across the globe. High quantities of grains are stored in warehouses, and fumigants, are majorly used in these warehouses for rodent control. In addition, sprays of zinc phosphide are used against mouse plagues in Australia.

Request for Sample Pages of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=189089498

Asia Pacific is expected to be the fastest-growing region with a CAGR of 6.5% during the forecast period.

The Asia Pacific market is completely driven by the country markets of China, India, Japan, Australia, Thailand, Indonesia and few other Asian counties. As the world’s largest and most populous region, Asia Pacific is one of the key markets for rodenticides. Rodents are common pests present in agricultural fields. Annually, extensive volumes of agricultural produce are destroyed and contaminated by rodents. To meet the increase in demand for food products and to reduce the crop damages caused by rodents, the use of rodenticides has increased significantly in the region. The food retail, food manufacturing, pharmaceutical, hospitality, and residential sectors are expected to be major growth verticals in this market.Asia Pacific is expected to be the fastest-growing region during the forecast period due to several reasons. One of the major drivers of the market is the fact that agriculture is one of the most significant revenue-generating sectors in China and India. The growing population within the region is urging the farmers to provide a maximum yield to fulfill the demand of the increasing population. In such cases, the increasing crop damage and decreasing food production due to rodents are expected to leverage this market positively.

Key players in this market include Basf Se(Germany), Bayer Ag(Germany), Syngenta Ag(Switzerland), UPL Limited(India) & Neogen Corporation(US)